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Abstract
Urosepsis is a bacteraemia infection caused by an organism previously causing an infection in the urinary tract of a patient, a diagnosis which
has been classically confirmed by culture of the same species of bacteria from both blood and urine samples. Given the new insights afforded
by sequencing technologies into the complicated population structures of infectious agents affecting humans, we sought to investigate
urosepsis by comparing the genome sequences of blood and urine isolates of Escherichia coli from five patients with urosepsis. The results
confirm the classical urosepsis hypothesis in four of the five cases, but also show the complex nature of extra-intestinal E. coli infection in
the fifth case, where three distinct strains caused two distinct infections. Additionally, we show there is little to no variation in the bacterial
genome as it progressed from urine to blood, and also present a minimal set of virulence genes required for bacteraemia in E. coli based on
gene association. These suggest that most E. coli have the genetic propensity to cause bacteraemia.
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Introduction
Extra-intestinal pathogenic Escherichia coli (ExPEC) infections
are now the most common cause of healthcare-associated
infection, having overtaken cases of methicillin-resistant Staph-
ylococcus aureus in recent years (http://www.hpa.org.uk/Topics/
InfectiousDiseases/InfectionsAZ/ESBLs/), with a marked
increase in the number of cases of bacteraemia caused by
ExPEC being reported worldwide [1]. A large number of
ExPEC bacteraemia infections are believed to be cases of
urosepsis, where the bacteraemia stems from untreated
urinary tract infections (UTI). In urosepsis, E. coli causing
uncomplicated UTI in the bladder ascend to the kidneys and
then enter the bloodstream via the fluid exchange system in
the renal glomeruli [2] leading to bacteraemia, which can have
mortality rates as high as 33% in elderly hospitalized patients
[3].
Comprehensive studies of the pathogenesis of ExPEC have
led to a detailed understanding of the molecular basis of this
process at the microbial level. The current accepted paradigm
for ascending UTI involves initial exposure to the urethra and
travel to the bladder via flagella-mediated motility [4], whereby
attachment to bladder epithelial cells is mediated by type 1
fimbriae and possibly a combination of several other accessory
adhesins [5–7]. The bacteria then invade the epithelium and
form intracellular bacterial communities, allowing subsequent
detachment from the biofilm and escape [8]. At this stage the
bacteria may further ascend the urinary tract to the kidneys
where they cause pyelonephritis, with the production of P
fimbriae by the bacteria considered essential for this progres-
sion [9]. From here the proximity to the blood–fluid exchange
system of the renal glomeruli allows spillage of bacteria into
the bloodstream and establishment of bacteraemia.
Despite the wealth of information from in vitro and animal
challenge studies on the urosepsis model, all knowledge of
urosepsis in humans is based on the positive culture of E. coli
from urine and blood samples taken from the patient within a
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close time frame, and the extrapolation of experimental data.
Given the advances in sequencing technology we sought to
provide a definitive examination of urosepsis in humans by
genome sequencing ExPEC isolated from urine and blood
samples of five patients with urosepsis. Our results confirm
that the urosepsis hypothesis is applicable to humans but also
highlights a case where the bacteraemia was caused by a strain
different from two isolated strains co-infecting the urinary
tract. Additionally our genomic data, supported by screening of
a large bacteraemia isolate collection, questions the require-
ment for P fimbriae and uncovers a minimum virulence-
associated gene set associated with sepsis that appears to be
conserved across the species.
Methods
Five patients were identified as having urosepsis across two
hospitals in the East Midlands region of the UK. The urosepsis
definition was based on the isolation of a pure culture of E. coli
from the blood sample of a patient, from whom a pure culture
of E. coli had been isolated from a clinical urine sample within
the previous 48 h. The genomes of the ten isolates were then
sequenced using the Illumina Hiseq 2000 platform, assembled
using SOAPDENOVO and annotated using RATT. Single nucle-
otide polymorphisms (SNPs) were called by mapping using the
SMALT program and SAMTOOLS utilities. The SNPS were then
manually filtered using ARTEMIS to only call SNPs with a
minimum depth of 8, minimum quality score of 30, and
minimum allele frequency of 0.95. All remaining SNPs were
then manually checked against BAM files in ARTEMIS to ensure
that they were reliable and not in areas at the ends of reads or
in phage, insertion sequences or transposons, which are often
difficult to accurately map against.
The multilocus sequence typing of the isolates was deter-
mined according to the Achtman typing scheme (http://mlst.
ucc.ie/).
Results
Multilocus sequence typing data showed that in four of the five
cases the same sequence type (ST) was isolated from urine and
blood (Table 1), and that all four ST belonged to the
phylogroup B2 high pathogenic lineage of ExPEC [10]. Patient
5 showed the presence of the pandemic multidrug-resistant
E. coli ST131 [11] in the urine sample, but a classically non-
pathogenic phylogroup A E. coli ST10 in the blood sample. To
investigate this further a selection of colonies from the urine
plate were subjected to multilocus sequence typing uncovering
the presence of two different strains in the urine sample,
namely ST131 and an ST127, with no detection of the ST10
strain (Table 1). The genome sequence data for all strains are
represented diagrammatically in Fig. 1.
To definitively confirm that the blood and urine E. coli
isolates from patients 1–4 were indeed the same, SNP typing
was performed on the eight strains. In the absence of a
reference strain suitably close to all four identified STs to allow
common SNP typing we adopted the strategy of mapping the
Illumina sequencing data of the blood isolate against a
SOAPDENOVO annotated genome [12] of the corresponding
urine isolate. This was based on the rationale that the urine
isolate is the primary infectious agent, which then progresses
and possibly evolves during the ascension to bacteraemia. The
resulting SNP profile for the four matched cases (Table 2)
provides evidence that the strains causing the UTI are the
same as those causing the bacteraemia infection, with isolates
from patient 3 having no detectable difference across the
genome using our stringency settings. Additionally we could
not detect any sufficiently robust insertions or deletions across
any of the four cases using our selection criteria. We
determined the location of the seven SNPs across patients 1,
2 and 4 using the annotated urine isolate genomes. All but one
of the seven SNPs identified in our three remaining cases were
non-synonymous mutations and five of the SNPs, present
across all three cases were situated in the region of the
chromosome encoding the yeeV/yeeU toxin–antitoxin system,
with mutations in yeeV as well as the surrounding genes yeeT
and yeeW, which encode hypothetical proteins. This is
suggestive of a selection effect on the yee locus during
ascension from the bladder to bloodstream, as seen in other
loci of ExPEC strains isolated from individual patients [13]. In
sillico analysis of the SNP locations in the genes in P1, P2 and P4
(Fig. 2) failed to uncover any biological significance because of
the lack of characterization of the encoded proteins, including
absence of defined Pfam domains. In a further attempt to
characterize the biological relevance of the SNPs we compared
virulence phenotypes of our matched strains, assaying in vitro
cell adhesion and invasion, biofilm formation, motility, serum
resistance and cell morphology (Table 3). The only notable
differences were in serum resistance, particularly in patient 1,
which curiously also contains most SNPs between the blood
and urine isolate.
We performed comparative genomics across our five
bacteraemia isolate genome sequences paying attention to
genes previously described as ExPEC virulence factors in
published literature. Most strikingly isolates from patient 4
(ST1917 complex) and patient 5 (ST10) did not carry the pap
genes encoding P fimbriae, which has been previously consid-
ered essential for ascending UTI [9]. Similarly the high
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pathogenicity island HPI is also missing from ST10, as would be
expected for a phylogroup A strain, precluding it from being
considered as a necessary element for bacteraemia but not
from ascending UTI and bacteraemia given we cannot prove
the previous presence of the ST10 in the patient’s urinary
tract. Analysis of genes present across all five isolates identified
type 1 fimbriae (fim), flagella, the fes/fep iron acquisition
system, the cus heavy metal efflux system, and curli fimbriae
(csg) as being a minimum virulence-associated gene require-
ment for an ExPEC strain to be able to cause bacteraemia.
Screening with PCR for all five of the common bacteraemia
loci across a collection of 150 bacteraemia and 150 UTI ExPEC
isolates (collected over a 3-month period in 2011 in Notting-
ham University Hospital from unrelated clinical episodes)
TABLE 1. Details of patients and isolates which formed the study
Patient number and
source of isolate Patient information Escherichia coli sequence type Extended spectrum b-lactamase status by PCR
Patient 1 urine (P1U) 92-yearold female catheterized patient ST14 complex (ST550) –
Patient 1 blood (P1B) ST14 complex (ST550) –
Patient 2 urine (P2U) 92-year-old female catheterized patient ST131 –
Patient 2 blood (P2B) ST131 –
Patient 3 urine (P3U) 81-year-old female patient ST73 complex (ST1262) –
Patient 3 blood (P3B) ST73 complex (ST1262) –
Patient 4 urine (P4U) 51-year-old female patient. No
underlying co-morbidities
ST1917 –
Patient 4 blood (P4B) ST1917 –
Patient 5 urine (P5U1) 75-year-old male catheterized patient ST131 +
Patient 5 urine (P5U2) ST127 –
Patient 5 blood (P5B) ST10 –
FIG. 1. Comparative genome representation of the 11 genomes sequenced from five patients in our study. The isolates are colour coded by
patient, and show the clear relationship between the blood and urine isolates in patients 1–4, and the presence of three distinct strains in patient 5.
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revealed that these loci are present in all ExPEC in our strain
collection.
Given that the genes associated with the minimum virulence
factor requirement are commonly associated with various
E. coli pathotypes we sought to determine if there were
bacteraemia-specific factors in our five strains. To do this we
determined the core genome of our five bacteraemia isolates
by reciprocal BLAST searches [14] and then compared that to
the reference genome of UTI89, which was isolated from
uncomplicated cystitis [6] to allow identification of genes
unique to the core bacteraemia gene set. Only one locus was
present in our blood isolate genomes but not in the publically
available genomes of E. coli associated with uncomplicated UTI
or in E. coli K12 strains. The locus is a gene found in a ribose
ABC transport system that is present in Escherichia fergusonii
and is annotated as EFER_2514 to EFER_2523. Analysis of our
TABLE 2. Single nucleotide polymorphisms (SNPs) identified within blood isolates when compared with their corresponding
urine isolates
Patient isolates SNP position Gene SNPa Substitution
1 1453958 Hypothetical protein – Vgr-like family G?T Ser?Ile
1786733 Putative transport protein yebQ G?T Gly?Val
4531403 Toxin of toxin/anti-toxin system yeeV C?T Gly?Ser
4531448 Toxin of toxin/anti-toxin system yeeV A?G Ser?Pro
2 4163357 Hypothetical protein in toxin/anti-toxin operon yeeW G?T Synonymous
3 No detectable SNPs N/A
4 1039343 Hypothetical protein in toxin/anti-toxin operon yeeT G?A Gly?Glu
1039391 Hypothetical protein in toxin/anti-toxin operon yeeT G?T Gly?Val
aSNP differences are called with respect to the urine strain genome Fasta sequence, not with respect to the coding sequence of the gene.
P1 P4
P2
SNPs
SNPs
SNP
FIG. 2. ARTEMIS visualizations of the single nucleotide polymorphisms (SNPs) present in the blood isolates P1B (P1), P2B (P2) and P4B (P4) relative
to their associated urine isolate. The SNPs are represented as lines (indicated by SNP and arrow) created by importing the VCF output file from the
SAMTOOLS mapping pipeline into ARTEMIS. Their position relative to the coding sequence is denoted by the blue arrow representing the position of the
coding sequences relative to the SNPs. The DNA sequence (grey) and protein encoding amino acid sequence (blue) is magnified and presented to
show the position of the SNP and the resulting amino acid which is substituted (red circles).
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annotated bacteraemia isolate genomes suggested that two
(Patients 1 and 2) possess an identical operon situated in the
identical location between the entD gene of the fes/fep operon
and ybdK, with the other three carrying an orthologue of the
EFER_2520 gene but in different locations. Comparison with
the 15 available Phylogroup B2 ExPEC reference genomes on
NCBI (http://www.ncbi.nlm.nih.gov/genome?term=escherichia
%20coli) showed that the operon was absent in all but two
strains, SE15 and NA114, both of which are isolates belonging
to the highly pathogenic and drug-resistant ST131 lineage [15].
BLAST searches of the operon revealed that it is also present
in isolates of Klebsiella spp. and the plant pathogens Dickeya
spp. and Pantoea spp. but not in any other sequenced E. coli.
We also screened our 150 bacteraemia and 150 UTI E. coli
isolates by PCR for the gene EFER_2520. There was no
definitive association of this island with sepsis with carriage
rates of 31.4% in sepsis isolates and 27.2% in UTI isolates.
However, there was clear association of carriage of this
operon with the multidrug-resistant ST131 lineage, with 85%
of isolates in our strain collection (n = 39) being PCR positive
for the operon. This was not associated with extended
spectrum b-lactamase carriage in ST131.
Discussion
From a clinical perspective the understanding of ascending
urinary tract infection from bladder to kidney, and the
resulting translocation of bacteria into the bloodstream, as
the cause of urosepsis has been a well-defined process for
many decades. What is less well understood, despite decades
of fundamental research, is this process from the microbial
perspective. At a microbial pathogenesis level almost all our
understanding of the process of progression to urosepsis is
based on classical bacterial genetics studies on ExPEC strains
using model infection systems ranging from tissue culture cells
to mouse infection models [16–18]. From a bacteriological
perspective the confirmatory diagnosis of urosepsis is based
on isolation of pure culture from the blood sample of a patient
with preceding UTI, which is also usually based on pure
culture; hence, the link between the two episodes is based
purely on the presence of colonies of the same species in each
sample.
The introduction of genome sequencing into clinical micro-
biology has challenged long-held clinical and bacteriological
paradigms, ranging from how methicillin-resistant S. aureus and
cholera have spread globally [19,20], to how methicillin-
resistant S. aureus has emerged in hospitals at a local level [21].
Indeed, genome-scale investigations have unearthed variation
and relatedness among pathogens missed by classical clinically
utilized techniques [20] and because of their powerful level of
discrimination are now being used in clinical disease investi-
gations [22]. Given the fact that the association of ExPEC
strains with urosepsis is based solely on the presence of E. coli
on blood and urine culture plates, and that most of our
perceived knowledge of the mechanisms of ascending UTI and
urosepsis are based on surrogate models, we aimed to use the
power of genomics to provide the most comprehensive study
to date of urosepsis in human clinical cases.
Our analysis provided positive proof in four of our five
sample sets that the same strain of E. coli can progress from
UTI to bacteraemia in patients. More significantly we show
that the classical ascending UTI virulence factor P pili is not
present in all urosepsis isolates, and that there are just five loci
associated with the bacteraemia phenotype. These are flagella,
type 1 fimbriae, curli fimbriae, fes/fep iron acquisition system,
and the cus heavy metal efflux system, all of which are
commonly present across various E. coli pathotypes. Our
analysis also shows that during the progression from UTI to
bacteraemia there is little host imprint on the genome of the
organism, with a difference of just a few SNPs between the
blood and urine isolates and in one case no detectable
TABLE 3. Phenotypic comparison of matched isolates from patient urine and blood
Strain
Adhesiona
(cfu/mL)
Invasiona
(cfu/mL)
Biofilmb
37°C (A600) Motility
c
Serum resistanced
T0 T3
P1U 3.1 E + 05 12 3.0 + 5.00E + 05 0
P1B 7.4 E + 04 33 2.3 + 3.83E + 06 6.50E + 06
P2U 6.6 E + 05 1 E + 04 3.0 +++ 2.50E + 06 6.67E + 05
P2B 4.2 E + 05 2.2 E + 04 2.4 +++ 3.00E + 06 2.33E + 06
P3U 2.8 E + 05 25 2.8 +++ 3.50E + 06 5.17E + 05
P3B 1.5 E + 05 13 2.6 +++ 1.83E + 06 1.67E + 07
P4U 2.2 E + 05 8.3 E + 03 3.5 +++ 8.33E + 06 6.67E + 04
P4B 5.6 E + 06 1 E + 04 3.4 ++ 1.17E + 06 3.67E + 04
aAdhesion and invasion values represent CFU recovered from triplicate wells of infected T24 bladder epithelial cells in vitro. Assays were performed on three independent
occasions and values are representative values of the repeated experiments.
bBiofilm assays were performed at 37°C in static cultures in both Luria Broth (LB) and brain–heart infusion broth in a 96-well plate, with five wells per strain. Assays were
performed on three independent occasions and values are representative values of experiments repeated in LB broth.
cMotility assays were performed in duplicate on three independent occasions using semi sold LB agar incubated at 37°C. Values are semi-quantitative assessments of the levels of
observed motility across the agar plates in each assay.
dSerum resistance was performed by the addition of quantified numbers of bacteria to human serum and enumeration of surviving bacteria after 3 h, and was performed in
triplicate on two independent occasions.
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difference at all. Previous work on E. coli isolated from the
human bladder over time showed that there was considerable
host-specific imprint on the genome of the infectious agent
[23]; however, these changes were in E. coli inhabiting the
bladder over a prolonged time course. Our data suggests the
rapid nature of transition from urinary tract to bloodstream
results in very few selective changes in the organism. In three
of the four matched isolates where SNPs were identified there
was commonality in mutations occurring in the yeeV locus. This
is a toxin/anti-toxin locus core to E. coli which has been
suggested to play a role in cell shape and division [24,25]. The
significance of these mutations warrants further investigation
given that this is not a locus prone to mutation in long-term
evolutionary studies performed in E. coli [26], and that the
same locus was mutated in three of the four urosepsis cases.
The amino acid substitutions described should result in large-
scale changes to encoded proteins given the differences in
molecular weight and properties in the amino acids as a result
of the SNPs (Table 2); however, in the absence of character-
ization data for the proteins at this locus it is difficult to
attribute a defined effect to those substitutions, although there
is a clear correlation in our small data set between number of
mutations in the locus and increased resistance to human
serum as observed in P1U and P1B. This is currently the focus
of investigation in our laboratory.
The data for our fifth patient also highlight the limitations of
classical culture-based diagnosis of infectious disease. Despite a
pure E. coli present on the urine and blood culture plate of
patient 5, sequencing data clearly show the presence of at least
three clearly distinct strains of E. coli in the patient. This has
been seen before in familial outbreaks of enterohaemorrhagic
E. coli [27] and in ExPEC wound infections [13]. Perhaps more
importantly is the fact that there were two highly pathogenic
ExPEC strain types in the urine, including an extended
spectrum b-lactamase-positive ST131 strain, yet the causative
agent of the bacteraemia in the patient was a completely
antimicrobial-susceptible E. coli ST10 of phylogroup A origin.
In conclusion, we present genome-based data confirming
the classically held urosepsis hypothesis as well as highlighting
the true complexity of extra-intestinal E. coli infections. Our
genome association studies also suggest that the vast majority
of ExPEC found in nature have the genetic propensity to cause
bacteraemia in humans.
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